We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$166B
AUM Growth
-$16.1B
Cap. Flow
-$15.1B
Cap. Flow %
-9.07%
Top 10 Hldgs %
10.62%
Holding
5,226
New
685
Increased
1,364
Reduced
1,922
Closed
756

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Consumer Discretionary 8.97%
3 Financials 8.5%
4 Healthcare 8.44%
5 Industrials 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASAN icon
4426
CALL
Asana
ASAN
$2.25B
-20,000
Closed -$274K
ASHR icon
4427
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
-324,507
Closed -$10.7M
ASO icon
4428
Academy Sports + Outdoors
ASO
$2.86B
-10,642
Closed -$606K
ASPI icon
4429
ASP Isotopes
ASPI
$596M
-54,037
Closed -$289K
ASX icon
4430
ASE Group
ASX
$94.4B
-22,002
Closed -$354K
ATI icon
4431
PUT
ATI
ATI
$28.6B
-5,400
Closed -$620K
ATKR icon
4432
PUT
Atkore
ATKR
$3.16B
-5,000
Closed -$316K
ATO icon
4433
Atmos Energy
ATO
$28.4B
-73,350
Closed -$12.3M
AVDL
4434
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
-64,300
Closed -$1.39M
AVDL
4435
DELISTED
Avadel Pharmaceuticals
AVDL
-132,459
Closed -$2.85M
AVDL
4436
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
-11,600
Closed -$250K
AVXL icon
4437
CALL
Anavex Life Sciences
AVXL
$288M
-45,000
Closed -$160K
AVUV icon
4438
Avantis US Small Cap Value ETF
AVUV
$31.3B
-69,970
Closed -$7.14M
AXP icon
4439
PUT
American Express
AXP
$228B
-3,000
Closed -$1.11M
AZN icon
4440
CALL
AstraZeneca
AZN
$259B
-5,900
Closed -$1.08M
BAH icon
4441
CALL
Booz Allen Hamilton
BAH
$9.05B
-13,000
Closed -$1.1M
BAH icon
4442
PUT
Booz Allen Hamilton
BAH
$9.05B
-20,700
Closed -$1.75M
BBAI icon
4443
BigBear.ai
BBAI
$1.47B
-16,100
Closed -$74.8K
BBJP icon
4444
JPMorgan BetaBuilders Japan ETF
BBJP
$18.9B
-10,386
Closed -$684K
BCYC
4445
Bicycle Therapeutics
BCYC
$303M
-21,548
Closed -$153K
BDX icon
4446
Becton Dickinson
BDX
$52B
-23,916
Closed -$4.64M
BEAM icon
4447
Beam Therapeutics
BEAM
$2.93B
-27,935
Closed -$774K
BEKE icon
4448
KE Holdings
BEKE
$19.5B
-41,815
Closed -$718K
BEKE icon
4449
PUT
KE Holdings
BEKE
$19.5B
-78,200
Closed -$1.23M
BEN icon
4450
CALL
Franklin Templeton
BEN
$17.6B
-56,600
Closed -$1.35M

Similar funds

David Shaw's Q1 2026 Portfolio in Review

As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.

  • David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
  • David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
  • David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
  • David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
  • David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
  • David Shaw opened 685 new positions and closed 756 in Q1 2026.
  • David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.